Ardelyx Inc. Stock
Price
Target price
€3.83
€3.83
6.480%
0.238
6.480%
€1.00
21.03.23 / Tradegate
WKN: A116X0 / Name: Ardelyx / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Ardelyx Inc. Stock
A very strong showing by Ardelyx Inc. today, with an increase of €0.24 (6.480%) compared to yesterday's price.
Our community is currently high on Ardelyx Inc. with 4 Buy predictions and 1 Sell predictions.
However, we have a potential of -73.901% for Ardelyx Inc. as the target price of €1.00 is below the current price of €3.83.
For the coming years our community has positive and negative things to say abot the Ardelyx Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Unique positioning" there were negative voices in the community.
Ardelyx, Inc. is a biopharmaceutical company that focuses on the research, development, and commercialization of innovative medicines aimed at treating kidney and cardiovascular diseases. The company uses a unique approach to drug discovery, developing therapeutics that target ion channels and transporters, which play a critical role in regulating activities in the body. Ardelyx's lead product candidate, tenapanor, is being studied for the treatment of conditions such as hyperphosphatemia in patients with chronic kidney disease, irritable bowel syndrome with constipation, and diverticulosis. The company is listed on the NASDAQ exchange under the ticker symbol ARDX.
Pros and Cons of Ardelyx Inc. in the next few years
Pros
?
S********** s********
?
B****
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ardelyx Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ardelyx Inc. | 6.480% | 4.230% | 39.454% | 287.020% | 61.326% | -1.250% | - |
| Krystal Biotech | 0.720% | 1.460% | -4.795% | 11.200% | -7.333% | - | - |
| Hepion Pharmaceuticals Inc. | -2.420% | -9.743% | -14.700% | -37.288% | 139.427% | -59.238% | - |
| Champions Oncology Inc | -1.050% | -13.364% | -10.048% | -50.850% | -8.738% | -20.675% | - |
